Erasca, Inc.

US$14.41As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ERASHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (6.89%)
Div yield —
ROE (78.25%)
Biotechnology
Beta (5Y) 0.65
PE TTM —
TSR TTM 495.45%
Mkt cap US$5.040B
ROIC (22.74%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$14
(4.99%)
(88.00%)
Sell 1|1|3|0|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.22
0.23
0.24
0.26
28.76%
18.98%
15.96%
18.92%
Revenue$M
301.4
314.4
324.1
317.8
3.84%
10.93%
8.27%
5.29%
Peers (US$5.040B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.413
0.309
0.293
EBIT/Intx
1.320
0.394
0.379
Own earn%
(3.78)
(19.78)
(19.88)
Sh yield%
32.12
3.50
3.86
Owners
Insiders/Inst%
9.66
79.27
Short interest%
5.80
SBC / revenue%
4.53
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
1–8
$1 testx
−0.3
Incr. ROIC%
8